Status:
TERMINATED
Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section
Lead Sponsor:
Montefiore Medical Center
Conditions:
Pain, Referred
Eligibility:
FEMALE
17-40 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if giving an injection of numbing medication at the incision at the end of cesarean will help control pain AFTER cesarean delivery. This study seeks to assess...
Detailed Description
The study assesses addition of subcutaneous bupivacaine with and without epinephrine to the standard intrathecal morphine/fentanyl combination given during spinal anesthesia during elective cesarean d...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- elective cesarean delivery
- planned spinal anesthesia
- Exclusion criteria:
- Non-English speaking
- Urgent or emergent cesarean delivery
- Active labor \[defined as: \>4cm cervical dilation or regular contractions noted on tocometer (\>2 contractions in a 10 minute period for 30 consecutive minutes)\]
- Chronic antepartum opioid use
- History of substance abuse (alcohol or drug)
- Current tobacco use
- Chronic steroid use
Exclusion
Key Trial Info
Start Date :
July 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03383588
Start Date
July 19 2018
End Date
December 31 2018
Last Update
January 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein College of Medicine/ Montefiore Medical Center
The Bronx, New York, United States, 10461